Adc Therapeutics Sa
(ADCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 466,544 | 530,194 | 371,884 | 383,122 | 439,195 |
| Receivables | 30,218 | 15,896 | 2,079 | N/A | N/A |
| Inventories | 11,122 | 8,008 | 7,718 | N/A | N/A |
| Other current assets | 17,298 | 14,310 | 12,751 | 10,120 | 11,255 |
| TOTAL | $525,182 | $568,408 | $394,432 | $393,242 | $450,450 |
| Non-Current Assets | |||||
| PPE Net | 4,066 | 4,022 | 3,261 | 2,391 | 1,629 |
| Investments And Advances | 41,236 | 44,002 | 46,212 | 47,381 | 47,908 |
| Intangibles | 13,582 | 13,316 | 12,010 | 10,147 | 10,179 |
| Other Non-Current Assets | 33,906 | 8,231 | 8,471 | 8,544 | 3,526 |
| TOTAL | $92,790 | $69,571 | $69,954 | $68,463 | $63,242 |
| Total Assets | $617,972 | $637,979 | $464,386 | $461,705 | $513,692 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,575 | 6,575 | 6,193 | 3,594 | 3,631 |
| Accounts payable and accrued liabilities | 12,080 | 12,028 | 14,631 | 11,462 | 5,279 |
| Other current liabilities | 50,497 | 39,685 | 29,450 | 25,272 | 30,375 |
| TOTAL | $73,935 | $59,300 | $51,499 | $41,398 | $40,436 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 377,949 | 391,371 | 168,969 | 122,339 | 137,751 |
| TOTAL | $377,949 | $391,371 | $168,969 | $122,339 | $137,751 |
| Total Liabilities | $451,884 | $450,671 | $220,468 | $163,737 | $178,187 |
| Shareholders' Equity | |||||
| Common Shares | 6,445 | 6,445 | 6,445 | 6,314 | 6,314 |
| Retained earnings | -924,885 | -890,504 | -818,955 | -746,386 | -694,859 |
| Other shareholders' equity | 102,701 | 89,797 | 75,138 | 56,981 | 42,994 |
| TOTAL | $166,088 | $187,308 | $243,918 | $297,968 | $335,505 |
| Total Liabilities And Equity | $617,972 | $637,979 | $464,386 | $461,705 | $513,692 |